• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Meta-analysis finds sustained benefits of neurofeedback for kids with ADHD

July 3, 2018 by Dr. David Rabiner

Image result for neurofeedback adhd kids___

In neu­ro­feed­back treat­ment for ADHD, indi­vid­u­als learn to alter their typ­i­cal pat­tern of brain­wave activ­i­ty, i.e., EEG activ­i­ty, to one that is con­sis­tent with a focused and atten­tive state.

This is done by col­lect­ing EEG data from indi­vid­u­als as they focus on stim­uli pre­sent­ed on a com­put­er screen. Their abil­i­ty to con­trol the stim­uli, e.g., keep­ing the smile on a smi­ley face keep­ing a video play­ing, depends on their main­tain­ing an EEG state that reflects focused attention.

Over time, most indi­vid­u­als bet­ter at this. Sup­port­ers of neu­ro­feed­back argue that learn­ing to alter EEG activ­i­ty and focus bet­ter dur­ing train­ing even­tu­al­ly gen­er­al­izes to real-world tasks that require strong atten­tion skills, e.g., read­ing, home­work, etc.

Although many experts remain skep­ti­cal of this approach, despite numer­ous sup­port­ive stud­ies, a recent­ly pub­lished meta-analy­sis of neu­ro­feed­back treat­ment pro­vides impor­tant new support.

Results from 10 dif­fer­ent stud­ies were pooled for this meta-analy­sis. All were ran­dom­ized-con­trolled tri­als in which neu­ro­feed­back treat­ment was com­pared to a con­trol con­di­tion. Only stud­ies that used neu­ro­feed­back treat­ment pro­to­cols for which pri­or empir­i­cal sup­port was avail­able were included.

The Study:

Sus­tained effects of neu­ro­feed­back in ADHD: A sys­tem­at­ic review and meta-analy­sis (Euro­pean Jour­nal of Child and Ado­les­cent Psy­chi­a­try). From the abstract:

  • Neu­ro­feed­back (NF) has gained increas­ing inter­est in the treat­ment of atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD). Giv­en learn­ing prin­ci­ples under­lie NF, last­ing clin­i­cal treat­ment effects may be expect­ed. This sys­tem­at­ic review and meta-analy­sis address­es the sus­tain­abil­i­ty of neu­ro­feed­back and con­trol treat­ment effects by con­sid­er­ing ran­dom­ized con­trolled stud­ies that con­duct­ed fol­low-up (FU; 2–12 months) assess­ments among chil­dren with ADHD … Com­pared to non-active con­trol treat­ments, NF appears to have more durable treat­ment effects, for at least 6 months fol­low­ing treat­ment. More stud­ies are need­ed for a prop­er­ly pow­ered com­par­i­son of fol­low-up effects between NF and active treat­ments and to fur­ther con­trol for non-spe­cif­ic effects.

Par­tic­i­pants’ ages var­ied but most stud­ies includ­ed chil­dren between 8 and 12. Across the 10 stud­ies, 256 par­tic­i­pants received neu­ro­feed­back and 250 were ran­dom­ized to a con­trol condition.

Some stud­ies com­pared neu­ro­feed­back to an active con­trol, i.e., one known to pos­i­tive­ly impact ADHD symp­toms such as med­ica­tion treat­ment. In stud­ies with non-active con­trols, chil­dren in the con­trol con­di­tion received either no treat­ment or one with­out estab­lished efficacy.

Chil­dren treat­ed with neu­ro­feed­back received between 25 and 40 train­ing ses­sions that ranged from 30 to 5o min­utes; no addi­tion­al train­ing was pro­vid­ed dur­ing the fol­low-up peri­od. Chil­dren receiv­ing med­ica­tion typ­i­cal­ly con­tin­ued on it dur­ing follow-up.

All stud­ies col­lect­ed par­ent rat­ings of ADHD symp­toms at base­line, imme­di­ate­ly after neu­ro­feed­back treat­ment end­ed (post-test), and between 2–12 months lat­er (fol­low-up).

The Findings:

From base­line to post-test, there was a sig­nif­i­cant reduc­tion in par­ents’ rat­ing of atten­tion prob­lems for chil­dren receiv­ing neu­ro­feed­back; the mag­ni­tude of the reduc­tion cor­re­spond­ed to a ‘medi­um’ effect size. At fol­low-up, this reduc­tion per­sist­ed and increased in mag­ni­tude to what would be char­ac­ter­ized as a large effect.

For chil­dren in an ‘active’ con­trol group, e.g., med­ica­tion, large reduc­tions in inat­ten­tive symp­toms between base­line to post-test were found. These reduc­tions were larg­er than those for neu­ro­feed­back treatment.

Ben­e­fits remained sta­ble across the fol­low-up peri­od but did not increase. Thus, at fol­low-up, which ranged from 2–12 months after neu­ro­feed­back end­ed, symp­tom reduc­tions for the neu­ro­feed­back and active con­trol groups no longer dif­fered. Sim­i­lar results were found for hyper­ac­tive-impul­sive symptoms.

Chil­dren in non-active con­trol groups showed a small reduc­tion in inat­ten­tive symp­toms at post-test that was no longer evi­dent at fol­low-up. There were no reduc­tions at either time point for hyper­ac­tive impul­sive symptoms.

Summary and implications:

The impor­tant find­ings from this meta-analy­sis of 10 ran­dom­ized-con­trolled stud­ies of neu­ro­feed­back treat­ment for chil­dren with ADHD are:

  1. Neu­ro­feed­back yields sig­nif­i­cant reduc­tions in par­ent rat­ings of inat­ten­tive and hyper­ac­tive-impul­sive symptoms.
  2. These reduc­tions per­sist for up to 2–12 months after neu­ro­feed­back ends.
  3. Although med­ica­tion has a larg­er ini­tial effect, symp­tom reduc­tions result­ing from neu­ro­feed­back and med­ica­tion may be com­pa­ra­ble over a more extend­ed time period.

What does this mean for par­ents con­sid­er­ing neu­ro­feed­back treat­ment for their child?

First, this pro­vides a strong basis to expect ben­e­fits if treat­ment is well-admin­is­tered and an estab­lished pro­to­col is used.

Sec­ond, while treat­ment is long (25–40 ses­sion) — and can be expen­sive — ben­e­fits are like­ly to per­sist after treat­ment ends.

Third, because med­ica­tion yields larg­er symp­tom reduc­tions in the short-term, it will be espe­cial­ly impor­tant to con­sid­er when symp­toms are pro­nounced and imme­di­ate symp­tom reduc­tion is essential.

A few impor­tant caveats. First, although neu­ro­feed­back ben­e­fits per­sist­ed through the fol­low-up peri­od, whether they extend beyond the time frames used in these stud­ies is unknown.

Sec­ond, while par­ent rat­ings of chil­dren’s symp­toms are an impor­tant out­come mea­sure, oth­er impor­tant mea­sures were not includ­ed. For instance, teacher reports were not includ­ed, nor were mea­sures of aca­d­e­m­ic or social functioning.

One should not assume that reduc­tion in core ADHD symp­toms nec­es­sar­i­ly trans­lates into improve­ment in these impor­tant func­tion­al out­comes. This is a lim­i­ta­tion of many stud­ies in the ADHD field.

Final­ly, as with any treat­ment, not all chil­dren receiv­ing neu­ro­feed­back will ben­e­fit. One should not assume that because neu­ro­feed­back helps chil­dren with ADHD, on aver­age, it will nec­es­sar­i­ly help any indi­vid­ual child. This is also true for med­ica­tion, although in most cas­es the impact of med­ica­tion can be deter­mined more quickly.

An impor­tant ques­tion is whether find­ings from this study pro­vide a strong basis for con­clud­ing that neu­ro­feed­back treat­ment is effec­tive for ADHD.

Some sci­en­tists would argue that they do not. The rea­son is that although these were ran­dom­ized-con­trolled tri­als, par­ents were aware that their child was receiv­ing neu­ro­feed­back and this may have influ­enced their ratings.

For these sci­en­tists, con­clu­sive proof requires a ran­dom­ized con­trolled tri­al in which some chil­dren receive real neu­ro­feed­back while oth­ers receive ‘sham’ feed­back, i.e., feed­back that is not tied to their actu­al EEG activity.

This would cor­re­spond to receiv­ing a place­bo pill in a med­ica­tion tri­al. Only through such a design could par­ents and oth­er raters remain ‘blind’ to treat­ment and thus pro­vide rat­ings not biased by expectan­cy effects.

This type of study is nec­es­sary to con­clude that chil­dren improve because of the actu­al feed­back they receive on their EEG state, and not because of oth­er aspects of treat­ment that accom­pa­ny this.

– Dr. David Rabin­er is a child clin­i­cal psy­chol­o­gist and Direc­tor of Under­grad­u­ate Stud­ies in the Depart­ment of Psy­chol­o­gy and Neu­ro­science at Duke Uni­ver­si­ty. He pub­lish­es the Atten­tion Research Update, an online newslet­ter that helps par­ents, pro­fes­sion­als, and edu­ca­tors keep up with the lat­est research on ADHD.

Related articles:

  • Study sug­gests the real deficit under­ly­ing Atten­tion Deficit Dis­or­ders is not Atten­tion, but Work­ing Memory
  • What are cog­ni­tive abil­i­ties and how to boost them?
  • Study shows why chil­dren with ADHD should be reeval­u­at­ed each year: Atten­tion prob­lems per­ceived by teach­ers are far less sta­ble than we imagine
  • Rates of ADHD diag­no­sis and med­ica­tion treat­ment con­tin­ue to increase substantially

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Attention & ADD/ADHD, Brain/ Mental Health, Education & Lifelong Learning, Technology & Innovation Tagged With: adhd, ADHD-symptoms, brainwave, EEG activity, meta-analysis, Neurofeedback, training

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 12,516 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2023 SharpBrains. All Rights Reserved - Privacy Policy